Inactive Instrument

International Isotopes Inc. Stock OTC Bulletin Board

Equities

US45972C1027

Industrial Machinery & Equipment

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for International Isotopes Inc.
Sales 2022 11.18M Sales 2023 12.27M Capitalization 20.79M
Net income 2022 - Net income 2023 - EV / Sales 2022 2.01 x
Net Debt 2022 5.74M Net Debt 2023 5.66M EV / Sales 2023 2.16 x
P/E ratio 2022
54.8 x
P/E ratio 2023
-23.8 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 27.22%
More Fundamentals * Assessed data
An unknown buyer has entered into an Asset Purchase Agreement to acquire Unused assets in FEP business of International Isotopes Inc for $12.5 million. CI
International Isotopes Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
International Isotopes Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
International Isotopes Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
International Isotopes Inc. Announces Executive Changes CI
International Isotopes Inc. Appoints Shahe Bagerdjian to Serve as a Member of the Board CI
International Isotopes Inc. acquired Nuclear lung ventilation product line from Amici Inc. CI
Earnings Flash (INIS) INTERNATIONAL ISOTOPES Reports Q1 EPS $0.00 MT
International Isotopes Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
International Isotopes Inc. Announces Shahe Bagerdjian Appointed as President of the Company, Effective Immediately CI
International Isotopes Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
International Isotopes Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
International Isotopes Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Tranche Update on International Isotopes Inc.'s Equity Buyback Plan announced on January 26, 2021. CI
International Isotopes Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
Managers TitleAgeSince
Chief Executive Officer 60 23-05-07
Director of Finance/CFO 40 19-03-31
Director/Board Member 67 01-05-31
Members of the board TitleAgeSince
Chairman 56 02-04-23
Director/Board Member 67 01-05-31
Director/Board Member 72 17-08-01
More insiders
International Isotopes Inc. manufactures a range of nuclear medicine calibration and reference standards. Its Theranostics Products Segment includes production and distribution of Iodine-131 generic drug products and various isotopically pure radiochemicals. Its Cobalt Products segment includes management of a cobalt irradiation contract, fabrication of cobalt capsules for teletherapy or irradiation devices, and recycling of expended cobalt sources. Its Nuclear Medicine Standards segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. Its Fluorine Products segment is involved in the production of small-scale qualification samples of purity fluoride gas for various industrial applications, and development of laboratory and analytical processes.
More about the company